News & Events
-
December 22, 2021
Welcome uMotif
C-Path is proud to welcome uMotif as the newest member of its Electronic Patient-Reported Outcome Consortium. Comprised of 15 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, ePRO Consortium members collaborate in a pre-competitive environment to support and conduct novel research, design and...... -
August 23, 2021
ePRO Consortium Welcomes Medable
C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Comprised of 14 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, ePRO Consortium members collaborate in a pre-competitive environment to support and conduct novel research, design and deliver educational resources, and develop and disseminate best practice recommendations for the electronic collection of clinical outcome data. Welcome aboard, Medable!
-
August 14, 2020
ePRO Consortium Announces Publication of Open Access Article
C-Path’s ePRO Consortium is pleased to announce that “Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?” was published online by Applied Clinical Trials on August 14, 2020. The article examines ways to optimize the time and effort ethics committees invest in fulfilling their human subjects protection remit while streamlining the submission process.
-
April 10, 2020
ePRO Consortium Announces COVID-19 Risk Assessment and Mitigation Strategies for Sponsors and eCOA Providers for Collection of PRO Data through Clinical Sites
In collaboration with C-Path’s PRO Consortium, the ePRO Consortium has developed the presentation titled “Coronavirus Disease 2019 (COVID-19): Risk Assessment and Mitigation Strategies for the Collection of Patient-Reported Outcome (PRO) Data through Clinical Sites.” This presentation focuses on the current challenges of capturing PRO data originally intended to be collected electronically (i.e., ePRO) from study participants during in-person visits to study sites. Recommended risk assessment and mitigation strategies for consideration by trial sponsors and eCOA providers to facilitate the continued collection of PRO data in clinical trials are provided.
Access the PDF: COVID-19: Risk Assessment and Mitigation Strategies for the Collection of Patient-Reported Outcome Data through Clinical Sites
-
March 26, 2020
ePRO Consortium Announces Open Access Article
In collaboration with the DIA Study Endpoints Community, C-Path’s ePRO Consortium is pleased to announce the open access article “Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials” is available online in the April 1, 2020 issue of Contemporary Clinical Trials. This article provides recommendations for the structure and content of an evidence dossier aimed at supporting a clinical trial endpoint derived from mobile sensor data as fit-for-purpose in regulatory decision making.
Link to article: https://www.contemporaryclinicaltrials.com/article/S1551-7144(20)30040-9/fulltext